ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending RBLX Q1 2026 Earnings EPS Beats Estimates Significantly Stock Rises on Narrower Loss VICR Q1 2026 Earnings EPS Surges Past Estimates with 1983 Surprise RBLX Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment SIDU Q1 2026 Earnings Loss Per Share Widens Amidst Operational Challenges EDN Q4 2024 Earnings Massive EPS Surprise Masks Broader Concerns as Stock Declines